CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
751-765 of 1026
Incorporation of guidelines-concordant immunotherapy in the perioperative setting of NSCLC
MinuteCE®Incorporation of guidelines-concordant immunotherapy in the perioperative setting of NSCLC
Luis Paz-Ares, MD, PhD
Helena Yu, MD
Matthew Gubens, MD, MS
Ira J. Goldberg, MD
Kausik Ray, MBChB, MD, MPhil
Christie Ballantyne, MD
Optimizing Outcomes in Patients With IgAN: Novel Therapies and Evolving Guidelines
CME/CEOptimizing Outcomes in Patients With IgAN: Novel Therapies and Evolving Guidelines
Jürgen Floege, MD
Jonathan Barratt, MD, PhD
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
MinuteCE®Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Akshay S. Desai, MD
John McMurray, MD
Understanding the Unmet Needs of Women Impacted by PTSD: A Comprehensive Overview
CME/CEUnderstanding the Unmet Needs of Women Impacted by PTSD: A Comprehensive Overview
Joseph F. Goldberg, MD
Akshay S. Desai, MD
John McMurray, MD
- advertisement
Empowering Choices: Navigating Early-Stage HR+, HER2- Breast Cancer with CDK4/6 Inhibition
CME/CEEmpowering Choices: Navigating Early-Stage HR+, HER2- Breast Cancer with CDK4/6 Inhibition
Joyce O'Shaughnessy, MD
Summarizing multidisciplinary strategies: Where do we go from here?
MinuteCE®Summarizing multidisciplinary strategies: Where do we go from here?
Gianluigi Savarese, MD
Gianluigi Savarese, MD
James Burton, DM, FRCP
Aaron Wong, MD
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
MinuteCE®A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
James Burton, DM, FRCP
Aaron Wong, MD
Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
MinuteCE®Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
Gianluigi Savarese, MD
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
CME/CENew Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Carolyn S. P. Lam, MBBS, PhD
Scott Solomon, MD
Mikhail Kosiborod, MD
- advertisement
CETP inhibition: Lessons from two decades of clinical trials
MinuteCE®CETP inhibition: Lessons from two decades of clinical trials
Stephen Nicholls, FRACP, FACC, FESC, FAHA
A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
MinuteCE®A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
Erin Michos
Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Erin Michos
